GenomeDx Biosciences

About:

GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care.

Website: http://www.genomedx.com

Twitter/X: genomedx

Top Investors: Merck, Baird Capital, CRG, Merck Global Health Innovation Fund, Aeris Capital

Description:

GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.

Total Funding Amount:

$50.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2008-01-01

Contact Email:

info(AT)genomedx.com

Founders:

Timothy J. Triche

Number of Employees:

51-100

Last Funding Date:

2019-03-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai